Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enovirine-centered antiretroviral therapy and PD-1 expression on CD8+ T cells in HIV with hypercholesterolemia
ChiCTR2500113428Phase 4Completed
- Sponsor
- Xixi Hospital of Hangzhou
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ainuovirine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Xixi Hospital of Hangzhou. Primary endpoints: Blood lipid levels, Lymphocyte subpopulation and 1 more. Started Nov 2025; status: completed.
02
Drugs
ainuovirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR2500113428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113428.